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Abstract 
Zinsser-Cole-Engmann syndrome, more commonly known as Dyskeratosis Congenita, is a heritable genodermato-
sis having an estimated incidence of 1 in 1 million people. It is important for an oral physician to be aware of this 
condition as oral leukoplakia occurs in this condition as part of a classic triad along with reticulate skin pigmentation 
and nail dystrophy. Besides these, there may be myriad multisystem involvement as well. These individuals have a 
high predilection for developing malignancies as well as other grave life-threatening conditions. Timely diagnosis 
and management of these cases may help improve their morbidity and mortality, for which oral physicians can play 
a major role in recognizing the cases. This will only be possible when more of such cases are reported in dental 
literature. Here we present a case report of a 30 year old male patient who reported to our department with all the 
characteristic features of the triad and a few additional findings concordant to the disease as well.
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Introduction
Detection of leukoplakia is a relatively common fin-
ding in day to day dental practice. However, its occu-
rrence as a part of a clinical syndrome is very rare. One 
such condition is Dyskeratosis congenita [DC]. It is a 
heritable genodermatosis, which was first described in 
1906 by Zinsser (1). Later Engmann and Cole reported 
other cases in detail and hence it is also known as Cole-
Engmann syndrome or Zinsser-Cole-Engmann syndro-
me. Classically, described as a triad of skin pigmenta-
tion, nail dystrophy and oral leukoplakia (2). DC is a 
fatal condition in which majority of the patients develop 
aplastic anemia and malignant transformation occur in 
the keratotic white patches which is of considerable in-
terest to an oral physician. Estimated incidence is 1 in 1 
million people. DC is genetically heterogeneous, with 
X-linked recessive, autosomal dominant and autoso-
mal recessive subtypes but majority of the cases show 
X-linked recessive inheritance. Because of this type of 
inheritance pattern, the ratio of men to women affected 
by the disorder is approximately 13:1. DC is most com-
monly caused by a mutated gene, DKC1, located on the 
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Considering the symptoms of skin pigmentation, nail 
dystrophy and white patch a provisional diagnosis of DC 
was made. Hematological investigations were carried 
out to detect any concomitant aplastic anaemia but the 
values were within normal limits. Family history was 
positive for brother, who passed away due to same con-
dition at a very young age. Pedigree analysis suggested 
Mendelian X-linked recessive pattern of inheritance. He 
gave a medical history of undergoing treatment for the 
dermal lesions. He had a history of burning micturition, 
headaches and showed signs of depression. There was 
no history of prior hospitalizations. Personal history re-
vealed history of smoking 1 pack of cigarettes per day 
since last 15 years. Patient was in a habit of taking a 
bland diet due to burning sensation.
Excisional biopsy of the oral mucosal lesion was taken. 
Histopathological report confirmed the clinical diag-
nosis of leukoplakia with areas of epithelium showing 
moderate to severe hyperparakeratosis, acanthosis 
of the spinous layer with submucosa showing dense 
mixed inflammation and vascularization. Some areas 
of moderate dysplasia were also seen with increased 
Nuclear:Cytoplasmic ratio, pleomorphic nuclei, imma-
ture keratinization (Fig. 3) and abnormal mitoses.
X chromosome. The mucocutaneous features of DC ty-
pically develop between ages 5 and 15 years. Here we 
present a case report of one such patient reporting to our 
department exhibiting the classic triad sans the hemato-
logical dysfunction.
Case Report 
A 30 year old, unmarried, illiterate, unemployed male 
reported to the Department of Oral Medicine and Ra-
diology, Government Dental College, Srinagar, with a 
chief complaint of ulcer on the lower lip. History and 
examination revealed various findings present since 
birth in the patient. General physical showed a normal 
intelligence with premature graying of hair, primary poi-
kiloderma with triad of skin atrophy, pigmentations and 
telangiectasias especially on the dorsum of hands, nail 
dystrophy with longitudinal splitting in one finger nail, 
adermatoglyphia [loss of dermal ridges on fingers and 
toes], plantar keratosis (Fig. 1), photophobia, epiphora 
[due to lacrimal stenosis], loss of eye lashes. Patient had 
progeria-like facies and mandibular retrognathism. On 
Intra-oral examination, ulcers were seen on the lower 
lip due to trauma from the upper centrals impinging on 
them. Homogenous leukoplakia of right buccal mucosa 
near commisure region was detected involving an area 
of approx. 2x1 cm. (Fig. 2) There was generalized perio-
dontitis and the patient had multiple carious and missing 
teeth. Lateral skull radiograph showed presence of intra-
cranial calcifications.
Fig. 1. Plantar keratosis.
Fig. 2. Leukoplakia near the right commissure region on buc-
cal mucosa.
Fig. 3. Immature keratinization seen in deeper layers (arrow).
Follow-up was done at 1 week, sutures were removed, 
however the surgical site showed relatively delayed 
wound healing which is attributable to the condition. 
Patient was prescribed a daily supplement of oral anti-
oxidants which included lycopenes, green tea extracts, 
wheat germ oil, calcium ascorbate, selenium dioxide and 
zinc sulphate. A diet chart was formulated specifically 
designed for the patient to meet his requirements. Coun-
seling was done for smoking habit cessation to which the 
patient has responded well, being tobacco-free for over 
a year now. He was taught self-examination of the oral 
cavity to be conducted at home along with meticulous 
oral hygiene maintenance. Since then, the patient reports 
for regular recalls every 3 months to our department and 
over the past one and a half year, there has been no recu-
rrence of the lesion or appearance of new lesions.
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Discussion
Dyskeratosis congenita [DC], an inherited syndrome, 
first described by Zinsser in 1910, is characterized by 
the triad of reticulated skin pigmentation, nail dystrophy 
[both occurring in 100% of cases], and white plaques 
[80% of cases]; typically occurring in the oral cavity. 
Other features occur with lower frequencies and invol-
ve virtually every organ system (3). DC is related to 
telomerase dysfunction; all genes associated with this 
syndrome [DKC1, TERC, TERT, TINF2 and NOP10] 
encode proteins in the telomerase complex responsible 
for maintaining telomeres at the ends of chromosomes. 
Patients with DC have reduced telomerase activity and 
abnormally short tracts of telomeric DNA compared 
with normal controls.
Oral manifestations of DC include leukoplakia most 
commonly affecting the tongue, followed by the buccal 
mucosa (4). Lichen planus or lichenoid lesions instead 
of leukoplakia have also been reported (5). Besides the-
se, severed periodontal destruction especially juvenile 
periodontitis has been reported which might be due to 
associated neutropenia (6). Increased incidence of dental 
caries has also been seen in such patients which has been 
postulated to be due to defects in enamel calcification 
(5).
Cannel H [1971] postulated the nature and changes in 
the oral manifestations of this condition in relation to 
time:
• Age 5-14 years- White patches of necrotic epithelium 
or possible candidal infections. Patches always prece-
ded by vesicles and ulcerations.
• Age 14-20 years- Recurrent ulcerations and erythro-
plakia.
• Age 2-30 years- Erosive leukoplakia and carcinoma.
Patients suffering from DC have been reported to have a 
markedly increased incidence of malignancies (8). The-
se include mucosal neoplasms, particularly squamous 
cell carcinoma of the mouth, nasopharynx, esophagus, 
rectum, vagina, or cervix. The development of Hogkin’s 
disease and adenocarcinoma have been recorded (9).
The question of ‘Why such a high incidence in DC pa-
tients?’ lead to Electron microscopy studies revealing 
that cells in dyskeratosis congenita have an embryonic 
immature nucleus, which have higher chances to un-
dergo malignant transformation (8). In addition, barrier 
zone of epithelium is less effective in dyskeratosis con-
genita than the normal epithelium causing increased per-
meability of noxious substances and carcinogens to the 
germinal layers (10).
The main causes of death are Bone marrow failure/im-
munodeficiency [~60-70%], pulmonary complications 
[~10-15%] and malignancy [~5-10%] (11).
There is no effective and curative treatment for DC. 
Some interceptive, preventive and palliative measures 
can be adopted for which an early diagnosis is essential. 
Patient should be kept under observation and recalled 
for periodic follow up. In follow-up visits biopsy and 
complete blood picture should be advised to detect any 
malignant changes in white patches or developing hae-
matopoietic disorder.
Chemotherapy with bleomycin or cyclophosphamide 
is effective for treating leukoplakia associated with DC 
(6). Tomita and Ishii reported that a vitamin A derivati-
ve, etretinate is effective for treating leukoplakia in DC 
(12). However, side effects like exfoliative cheilitis, an-
gular cheilitis and teratogenicity can occur. Excisional 
biopsy can also be indicated to eliminate the possibility 
of development of carcinoma in leukoplakic areas. For 
extensive lesions in which surgery is not possible admi-
nistration of steroids and testosterone can be used (6).
Use of the anabolic steroid oxymetholone and haema-
topoietic growth factors such as erythropoietin [epoetin 
alpha], granulocyte macrophage colony stimulating fac-
tor and granulocyte colony stimulating factor [filgras-
tim] can produce improvement in the haematopoietic 
function (13). The only long term cure for the haemo-
poietic abnormalities is allogeneic haematopoietic stem 
cell transplantation, but this is not without risk. There is 
still significant mortality associated with bone marrow 
transplants for DC patients when compared with other 
bone marrow failure syndromes. One of the main reasons 
for this is the high level of pulmonary/vascular compli-
cations that present in these patients probably as a result 
of the underlying telomere defect. In future gene therapy 
can provide an alternative therapy for management of 
this fatal condition. Nonmyeloablative hematopoietic 
SCT conditioning regimens [i.e., reduced-intensity con-
ditioning] with fludarabine may offer better outcomes. A 
2007 review showed a 22% mortality rate with reduced-
intensity conditioning in DC treatment versus a 71% 
mortality rate with traditional myeloablative regimens. 
Treatment regimes exploring the combination of fluda-
rabine, cyclophosphamide and anti-thymocyte globulin, 
are being explored (14).
We conclude that a long-standing history of a white patch 
in the mouth in a young patient, with or without signifi-
cant history of tobacco usage, occurring concomitantly 
with mucocutaneous and systemic features as described 
should invoke a suspicion of a heritable genodermato-
sis such as Dyskeratosis congenita. Such patient have a 
high predilection for malignancies and an oral physician 
can play a pivotal role in detecting and managing such 
cases as a part of a multidisciplinary team.
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